Chronix Biomedical and University of Texas MD Anderson Cancer Center Release: Cell-Free DNA Accurately Correlates With Breast Cancer DNA  
5/31/2013 10:17:03 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CHICAGO--(BUSINESS WIRE)--Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled “Modulation of breast cancer cell-free DNA with surgical resection” (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

Help employers find you! Check out all the jobs and post your resume.